Proceedings: Preliminary observations on the human pharmacology of I.C.I. 66082 in normal volunteers.
作者信息
Graham B R, Littlejohns D W, Prichard B N, Scales B, Southorn P
出版信息
Br J Pharmacol. 1973 Sep;49(1):154P-155P.
Abstract
摘要
相似文献
1
Proceedings: Preliminary observations on the human pharmacology of I.C.I. 66082 in normal volunteers.论文集：ICI 66082在正常志愿者体内的人体药理学初步观察
Br J Pharmacol. 1973 Sep;49(1):154P-155P.
2
Proceedings: Antagonism by ICI 66082 of the effects of electrical stimulation on the right ansa subclavia of the dog.论文：ICI 66082对电刺激犬右锁骨下袢效应的拮抗作用
Br J Pharmacol. 1974 Mar;50(3):457P-458P.
3
4
Assessment of beta-blocking activity of trimepranol in man.曲美托洛尔在人体中的β受体阻滞活性评估。
Int J Clin Pharmacol Biopharm. 1978 Jun;16(6):279-84.
5
6
Letter: Beta receptors and renin release.信件：β受体与肾素释放
N Engl J Med. 1974 Jan 31;290(5):284. doi: 10.1056/NEJM197401312900516.
7
8
9
Initial clinical experience with I.C.I. 66.082, a new beta-adrenergic blocking agent, in hypertension.
Acta Med Scand. 1973 Dec;194(6):549-50. doi: 10.1111/j.0954-6820.1973.tb19489.x.
10
Effect of a new beta-adrenergic blocking agent, ICI 66o82, on exercise haemodynamics and airway resistance in angina pectoris.新型β-肾上腺素能阻滞剂ICI 66082对心绞痛患者运动血流动力学和气道阻力的影响。
Br Heart J. 1974 Dec;36(12):1194-1200. doi: 10.1136/hrt.36.12.1194.
引用本文的文献
1
The influence of urine pH on the renal excretion of ICI 66082 in man.尿液pH值对人体ICI 66082肾排泄的影响。
Br J Clin Pharmacol. 1974 Dec;1(6):513-4. doi: 10.1111/j.1365-2125.1974.tb01705.x.
2
A simple spectrophotofluorometric method for the measurement of I.C.I. 66082 in plasma and urine.一种用于测定血浆和尿液中 I.C.I. 66082 的简单分光光度荧光法。
Br J Clin Pharmacol. 1974 Feb;1(1):84-6. doi: 10.1111/j.1365-2125.1974.tb00213.x.
3
The distribution of propranolol, pindolol and atenolol between human erythrocytes and plasma.普萘洛尔、吲哚洛尔和阿替洛尔在人红细胞与血浆之间的分布。
Br J Clin Pharmacol. 1981 Oct;12(4):543-8. doi: 10.1111/j.1365-2125.1981.tb01263.x.
4
Clinical pharmacokinetics of atenolol--a review.阿替洛尔的临床药代动力学——综述
Eur J Drug Metab Pharmacokinet. 1982;7(2):81-91. doi: 10.1007/BF03188723.
5
An investigation into the cardiac and pulmonary beta-adrenoceptor blocking activity of ICI 66,082 in man.ICI 66,082对人体心脏和肺部β-肾上腺素能受体阻断活性的研究。
Br J Clin Pharmacol. 1975 Apr;2(2):151-7. doi: 10.1111/j.1365-2125.1975.tb01570.x.
6
Comparative potency of atenolol and propranolol as beta-adrenergic blocking agents in man.阿替洛尔与普萘洛尔作为人体β-肾上腺素能阻滞剂的相对效价。
Eur J Clin Pharmacol. 1976 Sep 30;10(5):297-303. doi: 10.1007/BF00565617.
7
8
Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension.阿替洛尔：对其药理特性以及在心绞痛和高血压治疗中的疗效的综述。
Drugs. 1979 Jun;17(6):425-60. doi: 10.2165/00003495-197917060-00001.
9
Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.β-肾上腺素受体阻断药的临床药代动力学
Clin Pharmacokinet. 1976;1(4):233-63. doi: 10.2165/00003088-197601040-00001.
10
Hypertension: which beta-blocker?高血压：选用哪种β受体阻滞剂？
Drugs. 1976 Dec;12(6):412-14. doi: 10.2165/00003495-197612060-00002.
本文引用的文献
1
The blocking effects of propranolol, practolol and ICI-66082 on the peripheral vascular responses to isoprenaline.普萘洛尔、普拉洛尔和ICI - 66082对异丙肾上腺素所致外周血管反应的阻断作用。
Br J Pharmacol. 1973 Jun;48(2):342P-343P.
2
A new type of cardioselective adrenoceptive blocking drug.一种新型的心脏选择性肾上腺素能阻断药物。
Br J Pharmacol. 1973 Jun;48(2):340P.
Zotero 插件